Rani Therapeutics Holdings Inc. (RANI)
RANI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.7332
-2.36% on the day
Market cap
$102.2M
Micro cap
Revenue · 2025
$1.6M
+58.9% on 2024
Net income · 2025
-$29.7M
-1817.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | RANI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001856725 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | CA |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.6M |
| Net income | -$29.7M |
| Operating income | -$38.3M |
| Net margin | -1817.1% |
| Operating margin | -2346.0% |
| Revenue growth | +58.9% |
| Cash | $18.6M |
| Total assets | $58.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 62.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-05-27 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-08-13 |
| Latest proxy DEFA 14A | DEFA14A | 2026-04-16 |
Source: SEC EDGAR submissions feed, 380 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals Inc. | $1.35 | -4.25% | $101.9M |
| INO | Inovio Pharmaceuticals Inc. | $0.9982 | -9.66% | $103.2M |
| UNCY | Unicycive Therapeutics Inc. | $3.73 | -7.90% | $103.9M |
| COYA | Coya Therapeutics Inc. | $4.47 | -6.96% | $105.0M |
| TNXP | Tonix Pharmaceuticals Holding Corp. | $6.13 | -7.68% | $105.1M |
| QUCY | Quantum Cyber N.V. | $1.12 | +8.74% | $97.7M |
| CPIX | Cumberland Pharmaceuticals Inc. | $7.17 | +2.43% | $107.4M |
| PLYX | Polaryx Therapeutics Inc. | $1.94 | -3.48% | $96.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier